(Press-News.org) In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus. Full findings of these studies appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Chronic HCV affects up to 170 million individuals worldwide and is a leading cause of end-stage liver disease. While HCV is curable with treatment of pegylated interferon (pegIFN) and ribavirin (RBV), many patients have difficulty tolerating these antiviral drugs. Prior studies have shown that 9% to 22% of patients enrolled in phase III trials of pegIFN plus RBV require modification of their dose due to hemolytic anemia brought on by the drugs. A reduction in RBV limits treatment efficacy, thus impacting the viral clearance success rate.
Alessandra Mangia, M.D., from Casa Sollievo della Sofferenza Hospital in Italy, and colleagues evaluated the association between ITPA variants and anemia in a cohort of 238 Caucasian patients treated with variable pegIFN and weight-based doses of RBV. The research team found that the ITPA variants were strongly and independently associated with protection from anemia, but did not provide an increase in sustained virological response.
"When anemia develops only four weeks after the start of treatment, physicians are required to immediately reduce ribavirin dosages. This early reduction will affect the overall duration of treatment which, with the combination of pegIFN and RBV, lasts 24 weeks for patients infected with HCV genotypes two and 3 (G2/3) and 48 weeks for patients with HCV genotype one (G1) infection. Currently, only the use of the drug erythropoietin (EPO)—an expensive drug that due to its high cost cannot be reimbursed in several countries—might prevent unsuccessful antiviral treatment in these cases," explained Dr. Mangia.
"Our findings demonstrated that ITPA variants are strongly associated with protection from week four anemia and help us in selecting in advance who will need early ribavirin dose reduction and possibly supportive EPO treatment. This may lead to a more rational use of economical resources and to an individualized use of supportive EPO treatment," concluded Dr. Mangia. "Patients with a genetic profile that included the two ITPA variants may be safely administered higher doses of RBV, increasing the likelihood of HCV elimination after treatment—an important finding given that to achieve viral clearance high dosages of RBV need to be used in the early phases of treatment."
A related study led by Fumitaka Suzuki, M.D., from Toranomon Hospital in Japan found similar results in its cohort of 61 Japanese patients with HCV. Patients in this study received a triple therapy of pegINF, RBV and the protease inhibitor, telaprevir. Dr. Suzuki and colleagues found that ITPA variants impacted blood levels; however a sustained virological response could be achieved with careful monitoring of anemia and prompt adjustment of RBV dose. The authors suggest that future investigation of the influence of ITPA gene variants on RBV-induced anemia are needed on larger scales and on patients of various ethnicities.
INFORMATION:
Article: "ITPA Genetic Variants are Protective Against Anemia During Antiviral Therapy for G2/3 HCV, but Do Not Decrease the Need for RBV Dose Reduction or Increase SVR." Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Paul J. Clark, Susanna Naggie, Hans L. Tillmann, Keyur Patel, Andrew J. Muir, Kevin V. Shianna, Leonardo Mottola, Daniela Petruzzellis, Mario Romano, Fernando Sogari, Domenico Facciorusso, David B. Goldstein, John G. McHutchison, Alessandra Mangia. Hepatology; Published Online: January 10, 2010 (DOI: 10.1002/hep.24068); Print Issue Date: February 2011. http://onlinelibrary.wiley.com/doi/10.1002/hep.24068/abstract.
Article:"Influence of ITPA Polymorphism on Decreases of Hemoglobin during Treatment with Pegylated IFN, Ribavirin and Telaprevir." Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Kazuaki Chayama, Naoyuki Kamatani, Yusuke Nakamura, Yuzo Miyakawa and Hiromitsu Kumada. Hepatology; Published Online: January 18, 2010 (DOI: 10.1002/hep.24058); Print Issue Date: February 2011. http://onlinelibrary.wiley.com/doi/10.1002/hep.24058/abstract.
These studies are published in Hepatology. Media wishing to receive a PDF of the articles may contact healthnews@wiley.com.
About the Journal
Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Hepatology is published on behalf of the American Association for the Study of Liver Diseases (AASLD). For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 .
About Wiley-Blackwell
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.
A climate tax corresponding to €60/ton CO2eq on meat and milk could reduce
greenhouse gas emissions from European agriculture by around seven per cent. If the land made available is used for bioenergy production, the decrease in emissions can be six times greater. This is shown by the researchers Kristina Mohlin, Stefan Wirsenius and Fredrik Hedenus, University of Gothenburg, Sweden, in an article published in the scientific journal Climatic Change.
Kristina Mohlin is a PhD student at the Department of Economics at the University of Gothenburg. She wrote the article ...
Foregut duplication cyst of the stomach is rare. Foregut duplications may or may not communicate with the gastrointestinal tract, and are usually diagnosed at a young age. There have been relatively few case reports describing this entity. Adenocarcinoma has been reported in four cases of gastric duplication cyst, but not in cysts that have a ciliated epithelium. Controversy exists concerning the embryological origin of these anomalies.
A research article to be published on January 7, 2011 in the World Journal of Gastroenterology addresses this question. The authors presented ...
MicroRNAs (miRNAs) regulate gene expression by mainly binding to the 3′-UTR of target mRNAs, leading to mRNA degradation or translation inhibition. Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies in China. Many studies have reported the miRNA expression profiles in Barrett's esophagus and esophageal adenocarcinoma. However, the pathobiological significance of aberrant miRNA expression in human ESCC has not been well documented.
A research article to be published on January 7, 2011 in the World Journal of Gastroenterology addresses ...
Hepatitis A virus (HAV) is an epidemiologically important virus with a worldwide distribution and causes acute hepatitis in humans. Acute HAV superinfection causes severe liver disease, acute liver failure and even higher mortality rates in patients with underlying chronic liver disease (CLD). Numerous studies have identified CLD as a risk factor for fulminant hepatitis and death from acute HAV infection.
A research article to be published on January 14, 2011 in the World Journal of Gastroenterology addresses this question. In this study, the authors investigated the ...
Acute diverticulitis is the most common complication of diverticular disease, and its clinical presentation varies from mild local inflammation to full-blown perforation. After resolution of an acute episode, the best management strategy is as yet undefined, due to the risk of further episodes and the risk associated with elective surgical resection. Historically, surgical resection has been advocated after one episode of complicated diverticulitis (diverticulitis with perforation of the bowel wall, which manifests as intra-abdominal abscesses or peritonitis) and after ...
Hemolysis is not uncommon during cardiovascular surgery, resulting in elevated circulating levels of cell-free oxyhemoglobin (FHb). The effect of hemolysis on intestinal microcirculation and gut wall integrity is unclear.
A research article to be published on January 14, 2011 in the World Journal of Gastroenterology addresses this question. An animal model was developed with FHb plasma levels similar to those found during cardiovascular surgery. The influence of circulating FHb on intestinal microcirculation was studied using fluorescent microspheres and intestinal injury ...
Low-dose acetylsalicylic acid (ASA) has been widely used for prevention of cardiovascular and cerebrovascular events. Several studies have shown that mucosal breaks caused by taking low-dose ASA occurred not only in the upper gastrointestinal tract but also in the lower gastrointestinal tract. However the cause of small bowel injury is not clear. One of the mechanisms of drug-induced small bowel damage is decrease in blood flow.
A research article to be published on January 14, 2011 in the World Journal of Gastroenterology addresses this question. The authors investigated ...
There is considerable interest in understanding transport and information pathways in living cells. It is crucial for both the transport of, for example, medicine into cells, the regulation of cell life processes and their signalling with their environment. New research in biophysics at the Niels Bohr Institute shows surprisingly that the transport mechanisms do not follow the expected pattern. The results have been published in the scientific journal Physical Review Letters.
The researchers studied fat molecules which are naturally occurring in cells. Using a special ...
The study, which was conducted at Sahlgrenska University Hospital in Gothenburg and at Alingsås Hospital, included 102 IBS patients between the ages of 18 and 65. Half the group was randomly allocated to increase their physical activity and the other half to maintain their usual lifestyle. Both groups received supportive phone calls from a physiotherapist. The active group increased their physical activity on their own, but with the advice and support from the physiotherapist.
"They were advised to perform moderate to vigorous physical activity for 20 to 30 minutes three ...
We know that people tend to be attracted to, date, and marry other people who resemble themselves in terms of personality, values, and physical appearance. However, these features only skim the surface of what makes a relationship work. The ways that people talk are also important. A new study published in Psychological Science, a journal of the Association for Psychological Science, finds that people who speak in similar styles are more compatible.
The study focused on words called "function words." These aren't nouns and verbs; they're the words that show how those ...
